Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Georgian Health Digest.
Press releases published on September 15, 2025
Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne IRVINE, CA, and HERSTAL, BELGIUM – September 15, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leading precision diagnostics company, …
Supporting Heart Health in Our Communities
Toronto, ON, Sept. 15, 2025 (GLOBE NEWSWIRE) -- LifeLabs is proud to support Heart Valve Voice Canada with a $5,000 donation to help raise awareness, detection, treatment, and support for Canadians affected by heart valve disease. Heart valve disease is a …
Parexel and Paradigm Health Partner to Expand Access and Efficiency in Clinical Trials
RALEIGH, N.C. and COLUMBUS, Ohio, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO), and Paradigm Health, a company rebuilding the clinical research ecosystem, today announced a strategic partnership to …
Cocrystal Pharma, Inc. Announces Closing of Up To $13 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
$4.7 million upfront with up to an additional approximately $8.3 million of potential aggregate gross proceeds upon the exercise in full of warrants BOTHELL, Wash., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc., (Nasdaq: COCP) (the “Company” or …
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc. Mont-Saint-Guibert, Belgium – September 15, 2025, 10:10pm CET / 4:10pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) and Nyxoah, Inc. (collectively, “Nyxoah” or the “Company …
Nyxoah Entame une Procédure Judiciaire pour Violation de Brevets Contre Inspire Medical Systems, Inc.
Nyxoah Entame une Procédure Judiciaire pour Violation de Brevets Contre Inspire Medical Systems, Inc. Mont-Saint-Guibert, Belgique – 15 septembre 2025, 22h10 CET / 16h10 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » ou la « Société »), une …
UPDATE – Kalaris Therapeutics Now Enrolling Phase 1b/2 Multiple Ascending Dose Study of TH103 in Neovascular Age-Related Macular Degeneration
Recently initiated Phase 1b/2 multiple ascending dose study intended to assess safety and efficacy in nAMD patients receiving four initial monthly doses of TH103 Phase 1b/2 study to inform dose selection for potential Phase 3 development program, with …
Women’s Health Collective Canada Launches Vital Talks National Seminar Series with the Support of Vichy Laboratoires
TORONTO, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Women’s Health Collective Canada (WHCC) is proud to announce the launch of Vital Talks, a new national online seminar series bringing together leading researchers, clinicians, and voices with lived experience to …
L’Association canadienne pour l’équité en santé des femmes (ACESF) lance la série de séminaires nationaux Conversations vitales avec le soutien de Vichy Laboratoires
TORONTO, 15 sept. 2025 (GLOBE NEWSWIRE) -- L’Association canadienne pour l’équité en santé des femmes (ACESF) est fière d’annoncer le lancement de Conversations vitales. Il s’agit d’une nouvelle série de séminaires nationaux en ligne rassemblant des …
AdCare Rhode Island Appoints New Executive Director as Facility Expansion Nears Completion to Serve More People Struggling with Addiction
NORTH KINGSTOWN, Rhode Island, Sept. 15, 2025 (GLOBE NEWSWIRE) -- AdCare Rhode Island has appointed Nicole Paliotti as its new Executive Director. As a trusted healthcare leader who has served the Rhode Island community for decades, Nicole brings extensive …
Kyverna Therapeutics to Highlight Interim Phase 2 Data from KYV-101 KYSA-6 Study in Myasthenia Gravis at AANEM 2025
Oral presentation to include topline efficacy and safety data for 6 patients with up to 9 months of follow up Enrollment for registrational Phase 3 portion of KYSA-6 trial in MG on track to initiate by year-end 2025 EMERYVILLE, Calif., Sept. 15, 2025 ( …
Immune Thrombocytopenic Purpura Market to Grow at a Paltry CAGR of 1.9% During the Forecast Period (2025–2034) | DelveInsight
New York, USA, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Immune Thrombocytopenic Purpura Market to Grow at a Paltry CAGR of 1.9% During the Forecast Period (2025–2034) | DelveInsight The recent approval of Sanofi’s WAYRILZ has shifted the dynamics of the immune …
National Association of Specialty Pharmacy Congratulates Industry Award Winners at its Record-Breaking 2025 Annual Meeting & Expo
Washington, DC, Sept. 15, 2025 (GLOBE NEWSWIRE) -- The National Association of Specialty Pharmacy (NASP) announces Industry Award winners at its record-breaking 2025 Annual Meeting …
Press release: SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM
SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM Ghent, Belgium, 15 September 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a …
Organic & Natural Health Leads First-Ever My Health Alliance Lobby Day on Capitol Hill
WASHINGTON, Sept. 15, 2025 (GLOBE NEWSWIRE) -- On Sept. 10, more than 50 citizen lobbyists representing a consortium of 15 national nonprofits and organizations gathered on Capitol Hill for the first My Health Alliance Lobby Day, organized by the Organic …
Smile Hair Clinic Becomes the First Hair Transplant Clinic in the World to Receive A-Rated Certificate from TEMOS
ISTANBUL, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Smile Hair Clinic has been awarded an A rating by TEMOS International Healthcare Accreditation, one of the most respected global organizations for quality and safety in healthcare. With this achievement, Smile …
ProteoNic Launches 2G UNic Transposon Platform to Support Superior Cell Line Productivity and Ease of Use
Leiden, The Netherlands – September 15, 2025 – ProteoNic, a leader in premium vector technology for biologics and cell and gene therapy, today announced the launch of its novel 2G UNic® transposon platform, available for licensing alongside the expansion …